AzTrials
AzTrials

Achalasia, EsophagealNCT07287787

Comparative Study of Per-oral Endoscopic Myotomy (POEM) in Treatment - naïve Achalasia Patients Versus Patients With Previous Pneumatic Dilation

A study testing per-oral endoscopic myotomy (POEM) in people with Achalasia, Esophageal, run by Assiut University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

The aim of this study is to compare the clinical efficacy, safety, and technical outcomes of per-oral endoscopid myotomy( POEM )in treatment-naïve achalasia patients versus patients with previous pneumatic dilation. Study subjects: 1. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Achalasia, Esophageal
What is being tested?
per-oral endoscopic myotomy (POEM)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
No sites listed yet
Study dates
15 Dec 2025to 1 Sep 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patients diagnosed with achalasia (Chicago classification types I-III by High resolution manometry (HRM) ).

Who cannot join

  • Children below 18 yr.
  • Prior surgical myotomy.
  • pregnancy

About this study

The aim of this study is to compare the clinical efficacy, safety, and technical outcomes of per-oral endoscopid myotomy( POEM )in treatment-naïve achalasia patients versus patients with previous pneumatic dilation.

  • Study subjects:
Read more
  1. Inclusion criteria: Adult patients diagnosed with achalasia (Chicago classification types I-III by High resolution manometry (HRM) ).
  2. Exclusion criteria:
  3. Children below 18 yr.
  4. Prior surgical myotomy.
  5. pregnancy Groups:
  • Group I (Naïve group): Patients undergoing POEM as primary therapy.
  • Group II (Prior Pneumatic Dilation group): Patients undergoing POEM after failed or relapsed pneumatic dilation.

Data analyzed included the following:

  • Baseline: basic demographic information, Eckardt score , manometry(HRM) , timed barium esophagogram and history of pneumatic dilation .
  • Perioperative parameters (Disease duration, Surgical time, Length of hospital stay, mucosal edema, and mucosal injuries).
  • Intraoperative (mucosal perforation ,bleeding in submucosal space ,pneumoperitoneum ,pneumomediastinum,pneumothorax or incompelet myotomy )and postoperative complications (Infections,esophageal leak ,subcutaneous emphysema, GERD,esophagitis ) .
  • Post procedure symptoms evaluation (Eckardt score) at 1, 3\&6 months after the procedure .

Eckardt score :

It is a 12-point score which is as following :

0 1 2 3 Recent weight loss (kg) none <5 kg 5-10 kg >10 kg Dysphagia none occasional daily each meal Retrosternal chest pain none occasional daily each meal Regurgitation none occasional daily each meal

A score of ≥3 is suggestive of active achalasia.

POEM technique :

Briefly, the procedure included submucosal injection at the 5-6-o'clock position entry point, and mucosal incision at the posterior wall about 8-10 cm above the esophageal-gastric junction (EGJ), entry into the tunnel by clearing submucosal fibers, and then myotomy initiating about 2 cm down from the mucosal incision and extending 2-4 cm into the cardia. Afterwards, the mucosal incision will be closed using endoclips. In special circumstances, when fibrosis or adhesions present because of prior PD, the myotomy will be located in an area of normal (fibrosis-free) tissue, and a long myotomy will be made.

Technical success was defined as a successful completion of the entire POEM procedure. Clinical success was defined as a post-POEM Eckardt score of 3.

  • Research outcome measures:
  1. Primary (main): Clinical success at 3 and 6 months (Eckardt score ≤ 3 )
  2. Secondary (subsidiary):
  • Technical success
  • Procedure time
  • Intra- and post-operative complications.

Data management and analysis :

Data will be collected first in sheets, and then will be in Master sheet. Data of every patient will be coded. This will be done using SPSS. Categorical data were presented as number and percentage. Continuous data is presented as mean and standard deviation (SD) if normally distributed or median and interquartile range (IQR) if non normal distributed. Other test will be used according to the results and relations needed to be studied.

Being tested
per-oral endoscopic myotomy (POEM)
Medical subject headings
Esophageal Achalasia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • per-oral endoscopic myotomy (POEM)Procedure or surgery

    Briefly, the procedure included submucosal injection at the 5-6-o'clock position entry point, and mucosal incision at the posterior wall about 8-10 cm above the esophageal-gastric junction (EGJ), entry into the tunnel by clearing submucosal fibers, and then myotomy initiating about 2 cm down from the mucosal incision and extending 2-4 cm into the cardia. Afterwards, the mucosal incision will be closed using endoclips. In special circumstances, when fibrosis or adhesions present because of prior PD, the myotomy will be located in an area of normal (fibrosis-free) tissue, and a long myotomy will be made.

Study groups in NCT07287787
Study groupRoleWhat they receive
Group I (Naïve group): Patients undergoing POEM as primary therapy.Active comparatorNot described
Receives: Procedure: per-oral endoscopic myotomy (POEM)
- Group II (Prior Pneumatic Dilation group):Patients undergoing POEM after failed pneumatic dilationActive comparatorNot described
Receives: Procedure: per-oral endoscopic myotomy (POEM)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Clinical success at 3 and 6 months (Eckardt score ≤ 3 )

    Measured: 6 months

Secondary outcomes (3)
  1. - Technical success

    the procedure will be done completely or need to do premature myotomy or to be aborted due to fibrosis or any technical problem

    Measured: 1 day ( the day of the procedure )

  2. procedure time

    compare the procedure time between the 2 groups

    Measured: 1 day ( the day of the procedure)

  3. Intraoperative & post operative complications

    define intraoperative complications ( pneumoperitoneum, pneumothorax , mucosal perforation or bleeding ) and post operative complications ( Infections,esophageal leak ,subcutaneous emphysema, GERD,esophagitis ) and compare these complications between the 2 gruops.

    Measured: up to 6 months after the procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Dec 2025
  2. Study start15 Dec 2025 (estimated)
  3. Primary completion15 Apr 2027 (estimated)
  4. Study completion1 Sep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
randomized control trial
Masking
None (open label)
Enrolment
32 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07287787
Sponsor's protocol ID
04-2025-100435
Status last verified
Dec 2025
First submitted
24 Nov 2025
Last updated
17 Dec 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing per-oral endoscopic myotomy (POEM) in people with Achalasia, Esophageal, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 17 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Clinical success at 3 and 6 months (Eckardt score ≤ 3 ) (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in